JP2023540506A5 - - Google Patents

Info

Publication number
JP2023540506A5
JP2023540506A5 JP2023514771A JP2023514771A JP2023540506A5 JP 2023540506 A5 JP2023540506 A5 JP 2023540506A5 JP 2023514771 A JP2023514771 A JP 2023514771A JP 2023514771 A JP2023514771 A JP 2023514771A JP 2023540506 A5 JP2023540506 A5 JP 2023540506A5
Authority
JP
Japan
Prior art keywords
salt
lumateperone
cocrystal
diffraction pattern
powder diffraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023514771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540506A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/071366 external-priority patent/WO2022051770A2/en
Publication of JP2023540506A publication Critical patent/JP2023540506A/ja
Publication of JP2023540506A5 publication Critical patent/JP2023540506A5/ja
Priority to JP2026060121A priority Critical patent/JP2026117004A/ja
Pending legal-status Critical Current

Links

JP2023514771A 2020-09-04 2021-09-03 新規の塩、結晶および共結晶 Pending JP2023540506A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026060121A JP2026117004A (ja) 2020-09-04 2026-04-01 新規の塩、結晶および共結晶

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063075019P 2020-09-04 2020-09-04
US63/075,019 2020-09-04
PCT/US2021/071366 WO2022051770A2 (en) 2020-09-04 2021-09-03 Novel salts, crystals, and co-crystals

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026060121A Division JP2026117004A (ja) 2020-09-04 2026-04-01 新規の塩、結晶および共結晶

Publications (2)

Publication Number Publication Date
JP2023540506A JP2023540506A (ja) 2023-09-25
JP2023540506A5 true JP2023540506A5 (cg-RX-API-DMAC7.html) 2024-09-11

Family

ID=80492079

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023514771A Pending JP2023540506A (ja) 2020-09-04 2021-09-03 新規の塩、結晶および共結晶
JP2026060121A Pending JP2026117004A (ja) 2020-09-04 2026-04-01 新規の塩、結晶および共結晶

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026060121A Pending JP2026117004A (ja) 2020-09-04 2026-04-01 新規の塩、結晶および共結晶

Country Status (10)

Country Link
US (1) US20230312573A1 (cg-RX-API-DMAC7.html)
EP (1) EP4208434A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023540506A (cg-RX-API-DMAC7.html)
KR (1) KR20230104121A (cg-RX-API-DMAC7.html)
CN (1) CN116113622A (cg-RX-API-DMAC7.html)
AU (1) AU2021338439A1 (cg-RX-API-DMAC7.html)
CA (1) CA3186537A1 (cg-RX-API-DMAC7.html)
IL (1) IL300886A (cg-RX-API-DMAC7.html)
MX (1) MX2023002468A (cg-RX-API-DMAC7.html)
WO (1) WO2022051770A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3600325A4 (en) 2017-03-24 2021-01-06 Intra-Cellular Therapies, Inc. UNIQUE COMPOSITIONS AND PROCESSES
WO2019178484A1 (en) 2018-03-16 2019-09-19 Intra-Cellular Therapies, Inc. Novel methods
SMT202600133T1 (it) 2018-03-23 2026-05-12 Intra Cellular Therapies Inc Composti organici
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods
US20250352469A1 (en) 2024-05-16 2025-11-20 Intra-Cellular Therapies, Inc. Novel compositions, devices, and methods
CN118566395B (zh) * 2024-08-02 2024-10-25 则正(济南)生物科技有限公司 测定甲苯磺酸卢美哌隆口崩片中杂质含量的方法、应用和系统

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL281050B2 (en) * 2016-03-25 2023-04-01 Intra Cellular Therapies Inc A controlled or delayed release pharmaceutical preparation containing a deuterated compound
WO2017172811A1 (en) * 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Novel co-crystals
EP3600325A4 (en) * 2017-03-24 2021-01-06 Intra-Cellular Therapies, Inc. UNIQUE COMPOSITIONS AND PROCESSES
WO2018189646A1 (en) * 2017-04-10 2018-10-18 Dr. Reddy's Laboratories Limited AMORPHOUS FORM AND SOLID DISPERSIONS OF LUMATEPERONE p-TOSYLATE
WO2019067591A1 (en) * 2017-09-26 2019-04-04 Intra-Cellular Therapies, Inc. NEW SALTS AND CRYSTALS
BR112020024885A2 (pt) * 2018-06-06 2021-03-09 Intra-Cellular Therapies, Inc. Novos sais e cristais
RS67906B1 (sr) * 2018-06-11 2026-04-30 Intra Cellular Therapies Inc Sinteza supstituisanih heterociklično fuzionisanih gama-karbolina
US12144808B2 (en) * 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
WO2020112941A2 (en) * 2018-11-27 2020-06-04 Teva Czech Industries S.R.O Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof
EP4134101A1 (en) * 2019-07-07 2023-02-15 Intra-Cellular Therapies, Inc. Deuterated lumateperone for the treatment of the bipolar ii disorder
JP2022549335A (ja) * 2019-09-25 2022-11-24 イントラ-セルラー・セラピーズ・インコーポレイテッド 新規方法

Similar Documents

Publication Publication Date Title
JP3621707B2 (ja) ピリドン―縮合したアザ二環式―またはシチシン誘導体、その製法および嗜癖治療におけるその用途
JP2021527043A5 (cg-RX-API-DMAC7.html)
JP4764911B2 (ja) メタニコチン化合物のヒドロキシ安息香酸塩
JP4477097B2 (ja) 中枢神経系障害の治療のための(2s)−(4e)−n−メチル−5−[3−(5−イソプロポキシピリジン)イル]−4−ペンテン−2−アミンの多形形態
JP6592512B2 (ja) 三環式アトロプ異性体の化合物
JP2007528396A (ja) Hivインテグラーゼ阻害薬
JP2005509679A (ja) 4−(1,3,4−チアジアゾール−2−イル)−1,4−ジアザビシクロ−[3.2.2]ノナン誘導体、それらの製造およびそれらの治療的使用
JP2014074067A (ja) メシル酸イマチニブのf、g、h、iおよびk結晶形
KR102142797B1 (ko) 피리디닐아미노피리미딘 유도체의 메실레이트 염의 결정질 형태, 그의 제조 방법, 및 그의 용도
HUE034460T2 (en) Substituted tetrahydrocarbazole and carbazole carboxamide compounds useful as kinase inhibitors
KR20170137738A (ko) 부프레노르핀의 아세테이트 염 및 부프레노르핀의 제조방법
JP5134755B2 (ja) 4−(オキサゾロピリジン−2−イル)−1,4−ジアザビシクロ−[3.2.2]ノナン誘導体、それらの製造と治療的使用
TW201006813A (en) Novel compounds
HU197842B (en) Process for producing pharmaceutical compositions comprising 2-alkoxy-n-(1-azabicyclo/2.2.2/oct-3-yl)-benzamide derivatives
CN112638376B (zh) 取代的四氢环戊二烯并[c]吡咯、取代的二氢吡咯嗪、其类似物和其使用方法
US20110306633A1 (en) Selective m4 receptor antagonist and its medical use
KR100339115B1 (ko) 결정성3-(4-헥실옥시-1,2,5-티아디아졸-3-일)-1,2,5,6-테트라하이드로-1-메틸피리딘(+)l-하이드로겐타르트레이트,이의제조방법및이를포함하는약제학적조성물
WO2009053742A2 (en) Salts of nefopam and their use in therapy
CN117736193B (zh) 一种氘代稠环化合物及其制备方法与用途
JP2007269628A (ja) 医薬化合物の結晶
US6683089B2 (en) N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols
JP2005517013A (ja) N−アリルオキシエチル−1,2,3,4,5,6−ヘキサヒドロ−2,6−メタノ−3−ベンズアゾシン及びその薬剤としての使用
JP2008195654A (ja) ベンゾ[b]フラン化合物の新規結晶形
ES2230369T3 (es) Fumarato de amlodipina.
HK40047161A (en) Substituted tetrahydrocyclopenta[c]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same